Results 161 to 170 of about 65,799 (276)

Hospital burden of pneumococcal disease in Spain (2016-2022): A retrospective study. [PDF]

Hum Vaccin Immunother
Gil-Prieto R, Hernandez-Barrera V, Marín-García P, González-Escalada A, Gil-de-Miguel Á.   +4 more
europepmc   +1 more source

Efficacy of Pneumococcal Immunization in Patients with Renal Disease – What Is the Data? [PDF]

, 2004
J. Ben Robinson
openalex   +1 more source

Bacteremic pneumococcal pneumonia: arrhythmogenic disease

Revista Española de Quimioterapia, 2022
Serrano Fernández, Leyre, Ruiz Iturriaga, Luis Alberto, Zalacaín Jorge, Rafael   +2 more
openaire   +3 more sources

PCV20 for the prevention of invasive pneumococcal disease in the Mexican pediatric population: A cost-effectiveness analysis. [PDF]

Hum Vaccin Immunother
Huerta JL, Ta A, Vinand E, Torres GI, Wannaadisai W, Huang L.   +5 more
europepmc   +1 more source

Invasive Pneumococcal Disease in Patients Infected with HIV: Still a Threat in the Era of Highly Active Antiretroviral Therapy [PDF]

, 2004
Queralt Jordano, Vicenç Falcó, Benito Almirante, Ana María Planes, O. del Valle, Esteban Ribera, Óscar Len, Carles Pigrau, Albert Pahissa   +8 more
openalex   +1 more source

Prevention of Pneumococcal Disease in Mice Immunized with Conserved Surface-Accessible Proteins [PDF]

, 2004
Josée Hamel, Nathalie Charland, Isabelle Pineau, Catherine Ouellet, Stéphane Rioux, Denis Martin, Bernard R. Brodeur   +6 more
openalex   +1 more source

Pneumococcal disease and the impact of pneumococcal conjugate vaccines

, 2017
This thesis addresses various aspects on pneumococcal disease, pneumococcal conjugate vaccines (PCVs) and the societal impact of PCV implementation in children. Implementation of 7-valent pneumococcal conjugate vaccine (PCV7) in the Dutch national immunization program for infants led to a shift from vaccine to non-vaccine serotypes (i.e.
openaire   +2 more sources

Incidence of pneumococcal disease in children in Germany, 2014-2019: a retrospective cohort study. [PDF]

BMC Pediatr
Weaver J, Hu T, Podmore B, Barnett R, Obermüller D, Galetzka W, Qizilbash N, Haeckl D, Weiss T, Mohanty S, White M, Boellinger T.   +11 more
europepmc   +1 more source

Sisk et al. Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: Role of comorbid conditions and race. Ann Intern Med 2003 17;138:960-8 [PDF]

, 2004
Burton Zweiman, Marc E. Rothenberg
openalex   +1 more source

Pediatric invasive pneumococcal disease in Bolívar, Colombia: a descriptive cross-sectional study. [PDF]

Infez Med
Rodríguez WC, Mora-Salamanca AF, Santacruz-Arias J, Alvarado-Gonzalez JC, Saavedra L, Pinzón-Redondo H, Alvis Guzmán NR, Alvis-Zakzuk NR, Zakzuk J.   +8 more
europepmc   +1 more source